Effectiveness of thrombosis prevention with a low molecular weight heparin preparation in gynaecological patients undec going surgery: An open study

References

• Adolf J., Buttermann G., Weidenbach A., Gimeineder F. Optimierung der postoperative Tromboseprophylaxe in der Gynakologie. Geburtshilfe Frauenheilkd. 1978; 38: 98–1041. Adolf J., Buttermann G., Weidenbach A., Gimeineder F. Optimierung der postoperative Tromboseprophylaxe in der Gynakologie. Geburtshilfe Frauenheilkd. 1978; 38: 98–104
   PubMed Web of Science ®Google Scholar
• Agrifoglio G., Gabrielli L., Losa S. (1986) La diagnostica della trombosi venosa. “Eparina 86”, Proceedings of a meeting, BolognaItaly, 21–22 May, 1986. Egidi, Bologna, 99–1052. Agrifoglio G., Gabrielli L., Losa S. (1986) La diagnostica della trombosi venosa. “Eparina 86”, Proceedings of a meeting, BolognaItaly, 21–22 May, 1986. Egidi, Bologna, 99–105
   Google Scholar
• Bara L., Billaud E., Gramond G., Kher A., Samama M. Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration. Thromb. Res. 1985; 39: 631–6363. Bara L., Billaud E., Gramond G., Kher A., Samama M. Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration. Thromb. Res. 1985; 39: 631–636
   PubMed Web of Science ®Google Scholar
• Bergquist D., Hedner U., Sjorin E., Holmes E. Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously. Thromb. Res. 1983; 32: 381–3914. Bergquist D., Hedner U., Sjorin E., Holmes E. Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously. Thromb. Res. 1983; 32: 381–391
   PubMed Web of Science ®Google Scholar
• Bratt G., Tornebohm E., Lockner D., Bergstrom K. A human pharmacological study comparing conventional heparin and low molecular weight heparin fragments. Thromb. Haemost. 1985; 53: 208–2115. Bratt G., Tornebohm E., Lockner D., Bergstrom K. A human pharmacological study comparing conventional heparin and low molecular weight heparin fragments. Thromb. Haemost. 1985; 53: 208–211
   PubMed Web of Science ®Google Scholar
• Clarke Pearsons D. L., Coleman R. E., Syman J. S., Hinshaw W., Creasman W. T. Venous thromboembolism prophylaxis in gynaecologic oncology. A prospective, controlled trial of low-dose heparin. Am. J. Obstet. Gynecol. 1983; 145: 606–6096. Clarke Pearsons D. L., Coleman R. E., Syman J. S., Hinshaw W., Creasman W. T. Venous thromboembolism prophylaxis in gynaecologic oncology. A prospective, controlled trial of low-dose heparin. Am. J. Obstet. Gynecol. 1983; 145: 606–609
   PubMed Web of Science ®Google Scholar
• Coon W. W. Epidemiology of venous thromboembolism. Am. Surg. 1977; 186: 149–1647. Coon W. W. Epidemiology of venous thromboembolism. Am. Surg. 1977; 186: 149–164
   Google Scholar
• Duncan P. T., Merton R. E. A low molecular weight heparin compared with unfractionated heparin. Thromb. Res. 1982; 28: 343–3508. Duncan P. T., Merton R. E. A low molecular weight heparin compared with unfractionated heparin. Thromb. Res. 1982; 28: 343–350
   PubMed Web of Science ®Google Scholar
• Haremberg J., Gnasso A., Zimmermann R., Schettler G., Augustin J. Effetto di una eparina a basso peso molecolare sulla coagulazione e lipolisi. I. Somministrazione sottocutanea. G. Arterioscl. 1984; 3: 205–2159. Haremberg J., Gnasso A., Zimmermann R., Schettler G., Augustin J. Effetto di una eparina a basso peso molecolare sulla coagulazione e lipolisi. I. Somministrazione sottocutanea. G. Arterioscl. 1984; 3: 205–215
   Google Scholar
• Henny C. P., Ten Cate H., TenCate J. W., Surachno S., VanBronswijk H., Wilmink J. M., Ockelford P. A. Use of a new heparinoid as anticoagulant during acute haemodialysis of patients with bleeding complications. Lancet 1983; 1: 890–89310. Henny C. P., Ten Cate H., TenCate J. W., Surachno S., VanBronswijk H., Wilmink J. M., Ockelford P. A. Use of a new heparinoid as anticoagulant during acute haemodialysis of patients with bleeding complications. Lancet 1983; 1: 890–893
   PubMed Web of Science ®Google Scholar
• Kakkar V. V. Prevention of post-operative venous thromboembolism by a new low molecular weight heparin fraction. Nouv. Rev. Fr. Hematol. 1984; 26: 277–28211. Kakkar V. V. Prevention of post-operative venous thromboembolism by a new low molecular weight heparin fraction. Nouv. Rev. Fr. Hematol. 1984; 26: 277–282
   PubMedGoogle Scholar
• Kakkar V. V. (1986) Does prevention of venous thrombosis prevent pulmonary embolism and post-phlebitic syndrome?. “Eparina 86, Proceedings of a meeting”, BolognaItaly, 21–22 May, 1986. Egidi, Bologna, 153–15712. Kakkar V. V. (1986) Does prevention of venous thrombosis prevent pulmonary embolism and post-phlebitic syndrome?. “Eparina 86, Proceedings of a meeting”, BolognaItaly, 21–22 May, 1986. Egidi, Bologna, 153–157
   Google Scholar
• Kakkar V. V., Howe C. T., Nicolaides A. N., Franc C., Clarke M. B. Natural history of deep vein thrombosis. Lancet 1969; 2: 230–23313. Kakkar V. V., Howe C. T., Nicolaides A. N., Franc C., Clarke M. B. Natural history of deep vein thrombosis. Lancet 1969; 2: 230–233
   PubMed Web of Science ®Google Scholar
• Kakkar V. V., Murray W. J. G. Efficacy and safety of low molecular weight heparin (CY 216) in preventing postoperative venous thromboembolism: a co-operative study. Br. J. Surg. 1985; 72: 786–79114. Kakkar V. V., Murray W. J. G. Efficacy and safety of low molecular weight heparin (CY 216) in preventing postoperative venous thromboembolism: a co-operative study. Br. J. Surg. 1985; 72: 786–791
   PubMed Web of Science ®Google Scholar
• Kunz S., Briel R. C., Drahne A. Das Tromboserisiko nach abdominal und vaginaler Hysterektomye. Geburtshilfe Frauenheilkd. 1979; 39: 932–93715. Kunz S., Briel R. C., Drahne A. Das Tromboserisiko nach abdominal und vaginaler Hysterektomye. Geburtshilfe Frauenheilkd. 1979; 39: 932–937
   PubMed Web of Science ®Google Scholar
• Leyvraz P. E., Richard J., Bachmann F., Van Melle G., Treyvand J. M., Livio J. J., Candardjis G. Adjusted versus fixed-dose subcutaneous heparin in prevention of deep vein thrombosis after total hip replacement. N. Engl. J. Med. 1983; 309: 954–95816. Leyvraz P. E., Richard J., Bachmann F., Van Melle G., Treyvand J. M., Livio J. J., Candardjis G. Adjusted versus fixed-dose subcutaneous heparin in prevention of deep vein thrombosis after total hip replacement. N. Engl. J. Med. 1983; 309: 954–958
   PubMed Web of Science ®Google Scholar
• Lowe L. W. Venous thrombosis and embolism. J. Bone Joint Surg. 1981; 63: 155–16617. Lowe L. W. Venous thrombosis and embolism. J. Bone Joint Surg. 1981; 63: 155–166
   Web of Science ®Google Scholar
• Mastacchi R., Stanzani L., Barbanti M., Montecchi L., Bianchini P. Interaction of heparin and heparin fractions with human platelets. Thromb. Res. 1982; 28: 275–28018. Mastacchi R., Stanzani L., Barbanti M., Montecchi L., Bianchini P. Interaction of heparin and heparin fractions with human platelets. Thromb. Res. 1982; 28: 275–280
   PubMed Web of Science ®Google Scholar
• Melissari E., Scully M. R., Paes T., Kakkar V. V. The influence of LMW heparin on the coagulation and fibrinolytic response to surgery. Thromb. Res. 1985; 37: 115–12619. Melissari E., Scully M. R., Paes T., Kakkar V. V. The influence of LMW heparin on the coagulation and fibrinolytic response to surgery. Thromb. Res. 1985; 37: 115–126
   PubMed Web of Science ®Google Scholar
• Multicenter Trial. Dihydroergotamine-heparin prophylaxis of postoperative deep vein thrombosis. J.A.M.A. 1984; 251: 2960–296620. Multicenter Trial. Dihydroergotamine-heparin prophylaxis of postoperative deep vein thrombosis. J.A.M.A. 1984; 251: 2960–2966
   PubMed Web of Science ®Google Scholar
• Settembrini P. G., Viani M. P., Strinna M., Montorsi M., Fabiani C., Pisacreta M. (1986) La trombosi venosa profonda (TVP) in chirurgia. Aspetti epidemiologici e topografici. “Eparina '86”, Proceedings of a meeting, BolognaItaly, 21–22 May, 1986. Egidi, Bologna, 109–11621. Settembrini P. G., Viani M. P., Strinna M., Montorsi M., Fabiani C., Pisacreta M. (1986) La trombosi venosa profonda (TVP) in chirurgia. Aspetti epidemiologici e topografici. “Eparina '86”, Proceedings of a meeting, BolognaItaly, 21–22 May, 1986. Egidi, Bologna, 109–116
   Google Scholar
• Turpie A. G. G., Levine M. N., Hirsh J., Carter C. J., Jay R. M., Powers P. J., Andrew M., Magnani H. N., Hull R. D., Gent H. Double blind randomised trial of Org 10172, low molecular weight heparinoid, in prevention of deep vein thrombosis in thrombotic stroke. Lancet 1987; 1: 523–52722. Turpie A. G. G., Levine M. N., Hirsh J., Carter C. J., Jay R. M., Powers P. J., Andrew M., Magnani H. N., Hull R. D., Gent H. Double blind randomised trial of Org 10172, low molecular weight heparinoid, in prevention of deep vein thrombosis in thrombotic stroke. Lancet 1987; 1: 523–527
   PubMed Web of Science ®Google Scholar
• Yin E. T., Wessler S., Stoll P. J. Biological properties of the naturally occurring plasma inhibitor of activated factor X. J. Biol. Chem. 1971; 246: 3703–371123. Yin E. T., Wessler S., Stoll P. J. Biological properties of the naturally occurring plasma inhibitor of activated factor X. J. Biol. Chem. 1971; 246: 3703–3711
   PubMed Web of Science ®Google Scholar